RFP | March 11, 2011
U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases announces the availability of funding for a contractor to develop a vaccine component and a technology that accelerates the immune response to biodefense vaccines . . .